Silence Therapeutics plc Cash And Cash Equivalents At Carrying Value

Quick Answer

Silence Therapeutics plc reported Cash And Cash Equivalents At Carrying Value of $11.28 million for the year ending 2025.

  • Silence Therapeutics plc showed a decrease of -90.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Silence Therapeutics plc's annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Silence Therapeutics plc's Cash And Cash Equivalents At Carrying Value has declined by 83.6%.
  • Historical annual values: Fiscal year 2025: $11.28 million | Fiscal year 2024: $121.33 million | Fiscal year 2023: $68.79 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: